Archive
2019, Volume 5
2018, Volume 4
2017, Volume 3
2016, Volume 2
2015, Volume 1




Volume 5, Issue 1, June 2019, Page: 1-4
Tumors of the Submandibular Gland: Our Management Experience at Sylvanus Olympio University Hospital in Lomé
Winga Foma, Department of ENT/Head and Neck Surgery, Université de Lomé, Lomé, Togo
Bathokedeou Amana, Department of ENT/Head and Neck Surgery, Université de Lomé, Lomé, Togo
Haréfétéguéna Bissa, Department of ENT/Head and Neck Surgery, Université de Lomé, Lomé, Togo
Essobozou Pegbessou, Department of ENT/Head and Neck Surgery, Université de Lomé, Lomé, Togo
Koffi Amegbor, Department of Pathological Anatomy, Université de Lomé, Lomé, Togo
Essohanam Boko, Department of ENT/Head and Neck Surgery, Université de Lomé, Lomé, Togo
Eyawèlohn Kpemissi, Department of ENT/Head and Neck Surgery, Université de Lomé, Lomé, Togo
Received: Jan. 2, 2019;       Accepted: Jan. 24, 2019;       Published: Feb. 15, 2019
DOI: 10.11648/j.ijo.20190501.11      View  46      Downloads  8
Abstract
The purpose of this survey was to describe the epidemiological, diagnostic and therapeutic aspects of submandibular gland tumors in our practice setting. This was a descriptive retrospective study of submandibular gland tumors treated in the ENT and cervico-maxillofacial surgery department of the Sylvanus Olympio University Hospital over a period of 15 years. Data were collected from patient records. During the study period, 25 tumor cases were collected and operated, representing 38.46% of the surgical pathology of the submandibular gland. The sex ratio (m / f) was 0.56. The average age was 45.68 years old with extremes of 5 and 86 years old. The 45 to 60 age group was the most represented with 11 cases (44%). Submandibulectomy was performed in all patients with supraomohyoid lymph node dissection in 4 cases based on clinical and ultrasound criteria for malignancy and intraoperative findings. The histology of the operative specimens found 6 malignant tumors (24%) and 19 benign tumors (76%). The pleomorphic adenoma was the most common histological type with 12 cases (48%). The size of the tumor did not have a statistically significant impact on the benign or malignant nature of the tumor (p = 0.55). Similarly, the histological nature was not related to sex (p = 0.19). The immediate postoperative evolution was good in 22 cases and complicated in 3 cases. Two cases of carcinoma classified pT3 were referred for complementary radiotherapy. In conclusion, tumors of the submandibular gland are relatively rare and predominantly affect women in our context. The evolution under treatment is good but could still be improved by a good preoperative exploration including the fine-needle biopsy or even the MRI.
Keywords
Submandibular Gland, Salivary Gland Tumors, Pleomorphic Adenoma, Togo
To cite this article
Winga Foma, Bathokedeou Amana, Haréfétéguéna Bissa, Essobozou Pegbessou, Koffi Amegbor, Essohanam Boko, Eyawèlohn Kpemissi, Tumors of the Submandibular Gland: Our Management Experience at Sylvanus Olympio University Hospital in Lomé, International Journal of Otorhinolaryngology. Vol. 5, No. 1, 2019, pp. 1-4. doi: 10.11648/j.ijo.20190501.11
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Uro-Coste E. Tumeurs des glandes salivaires: État des lieux en 2009. Ann Pathol 2009; 29 (4): 274-85.
[2]
Preuss SF, Klussmann JP, Wittekindt C, Drebber U, Beutner D, Guntinas-Lichius O. Submandibular Gland Excision: 15 Years of Experience. J Oral Maxillofac Surg 2007; 65 (5): 953-7.
[3]
Lima SS, Soares AF, de Amorim RF, Freitas Rde A. Epidemiologic profile of salivary gland neoplasms: analysis of 245 cases. Rev Bras Otorrinolaringol 2005; 71 (3):3 35-40.
[4]
Dalgic A, Karakoc O, Karahatay S, Hidir Y, Gamsizkan M, Birkent H, et al. Submandibular triangle masses. J Craniofac Surg 2013; 24 (5): 529–31.
[5]
Btissam B, Saidi Z, Khaoula H, Youssef R, Lahcen A, Mouna K, et al. Les tumeurs primitives de la glande submandibulaire: à propos de 25 cas. Pan Afr Med J 2014; doi:10.11604/pamj.2015.22.232.7275
[6]
Ellies M, Laskawi R, Agrelebe C, Schott A. Surgical management of non-neoplastic diseases of the submandibular gland. A follow-up study. Int J Oral Maxillofac Surg 1996; 25: 285–89.
[7]
Adeyemo WL, Ajayi OF, Anunobi CC, Ogunlewe MO, Ladeinde AL, Omitola OG, et al. Tumours of the submandibular salivary gland: a clinicopathologic review of cases over a 17-year period. West Indian Med J 2009 Sep; 58 (4): 388-91.
[8]
Rapidis AD, Stavrianos S, Lagogiannis G, Faratzis G. Tumors of the submandibular gland: Clinicopathologic analysis of 23 patients. J Oral Maxillofac Surg 2004; 62: 1203–8.
[9]
Hamoir M, Lawson G, Andry G, Lothaire P, Sacre R, Remacle M, et al. Tumors of the submaxillary gland. Ann Otolaryngol Chir Cervicofac 1991; 108 (1): 26-9.
[10]
Just PA, Miranda L, Elouaret Y, Meatchi T, Hans S, Badoual C. Classification des tumeurs des glandes salivaires. Ann Otolaryngol Chir Cervicofac 2008; 125 (6): 331-40.
[11]
Pegbessou EP, Ndiaye M, Diom E, Thiam A, Diouf MS, Boube D, et al. Tumeurs sub-mandibulaires: profils épidémiologiques et histologiques. Pan Afr Med J 2014; doi: 10.11604/pamj.2014.18.64.2102
[12]
Halimi P, Gardner M, Petit F. Les tumeurs des glandes salivaires. Cancer Radiother 2005; 9: 251–60.
[13]
Baglin AC, Wassef M. Cytoponction des glandes salivaires: le pour et le contre. Ann Pathol 2007; 27: 1S69-1S80.
[14]
Kucuk U, Akoz G, Cakir E, Pala EE, Bayol U, Gumussoy M, et al. Documentation of the Salivary Gland Tumors: An institutional data from Turkey. Med Sci Discov 2015; 2 (1): 144-47.
[15]
Vargas PA, Gerhard R, Araujo Filho VJ, de Castro IV. Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo 2002; 57 (6): 271-6.
[16]
Vuhahula EAM. Salivary gland tumors in Uganda: clinical pathological study. Afr Health Sci 2004; 4 (1): 15-23.
[17]
Amana B, Pegbessou E, Boko E, Agoda P, Darre T, Kpemissi E, et al. Tumeurs malignes de la parotide: épidémiologie au Togo. Rev Stomatol Chir Maxillofac Chir Orale 2014; 115: 15-6.
Browse journals by subject